Novavax, Inc. (NVAX)
12.82
+0.16
(+1.26%)
USD |
NASDAQ |
Oct 13, 16:00
12.87
+0.05
(+0.39%)
After-Hours: 20:00
Novavax EPS Diluted (TTM) : -1.523 for June 30, 2026
EPS Diluted (TTM) Chart
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.523 |
| March 31, 2026 | -0.5826 |
| December 31, 2025 | 2.395 |
| September 30, 2025 | 1.784 |
| June 30, 2025 | 2.272 |
| March 31, 2025 | 2.651 |
| December 31, 2024 | -1.323 |
| September 30, 2024 | -2.260 |
| June 30, 2024 | -2.767 |
| March 31, 2024 | -3.179 |
| December 31, 2023 | -5.536 |
| September 30, 2023 | -6.377 |
| June 30, 2023 | -7.266 |
| March 31, 2023 | -14.38 |
| December 31, 2022 | -8.450 |
| September 30, 2022 | -17.35 |
| June 30, 2022 | -19.51 |
| March 31, 2022 | -17.73 |
| December 31, 2021 | -23.30 |
| September 30, 2021 | -14.82 |
| June 30, 2021 | -13.71 |
| March 31, 2021 | -9.256 |
| December 31, 2020 | -6.788 |
| September 30, 2020 | -5.221 |
| June 30, 2020 | -2.757 |
| Date | Value |
|---|---|
| March 31, 2020 | -4.145 |
| December 31, 2019 | -5.677 |
| September 30, 2019 | -7.118 |
| June 30, 2019 | -8.708 |
| March 31, 2019 | -9.421 |
| December 31, 2018 | -10.11 |
| September 30, 2018 | -10.73 |
| June 30, 2018 | -11.40 |
| March 31, 2018 | -12.20 |
| December 31, 2017 | -12.60 |
| September 30, 2017 | -13.60 |
| June 30, 2017 | -15.40 |
| March 31, 2017 | -18.00 |
| December 31, 2016 | -20.60 |
| September 30, 2016 | -22.20 |
| June 30, 2016 | -19.80 |
| March 31, 2016 | -15.60 |
| December 31, 2015 | -11.80 |
| September 30, 2015 | -8.60 |
| June 30, 2015 | -7.80 |
| March 31, 2015 | -7.80 |
| December 31, 2014 | -7.20 |
| September 30, 2014 | -6.00 |
| June 30, 2014 | -6.20 |
| March 31, 2014 | -6.20 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Moderna, Inc. | -7.985 |
| Merck & Co., Inc. | 1.251 |
| Pfizer Inc. | 0.7552 |
| Agenus, Inc. | 2.651 |
| Editas Medicine, Inc. | -0.7446 |